Abstract
Although several immunohistochemical markers are available, differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura is difficult. We have found that the immunoreactivity of manganese superoxide dismutase (MnSOD), an important antioxidant enzyme, is high in mesothelioma compared to healthy pleural mesothelium. The aim of the present study was to investigate whether MnSOD can be used in the differential diagnosis of malignant mesothelioma and metastatic adenocarcinoma of the pleura. MnSOD expression was assessed by using immunohistochemistry in biopsies of malignant mesothelioma (n = 35) and metastatic adenocarcinoma of the pleura (n = 21). MnSOD immunoreactivity was assessed semiquantitatively with and without microwave pretreatment. Fifteen of the 35 malignant mesotheliomas showed moderate or strong MnSOD expression without and 23 with microwave pretreatment, the corresponding figures for metastatic adenocarcinoma of the pleura being 1 and 2 out of 21 (P = 0.002 and P< 0.001, respectively by Fisher’s exact test). Only mesothelioma biopsies showed strong MnSOD reactivity, and it was never negative in mesothelioma, whereas one-third of the adenocarcinomas showed no MnSOD reactivity. In conclusion, MnSOD immunoreactivity can, combined with other markers, aid the differential diagnosis between malignant mesothelioma and metastatic adenocarcinoma of the pleura. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Arber DA and Weiss LM (1993) CD15: A review. Appl Immunohistochem 1: 17–30
Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principal of protein-dye binding. Anal Biochem 72: 248–254
Clyde BL, Kang BH, Slot JW, Vincent R and Crapo JD (1993) Distribution of manganese superoxide dismutase mRNA in normal and hyperoxic rat lung. Am J Respir Cell Mol Biol 8: 530–537
Cobbs CS, Levi DS, Aldape K and Israel MA (1996) Manganese superoxide dismutase expression in human central nervous system tumors. Cancer Res 56: 3192–3195
Coursin DB, Chilia HP, Sempf J, Oberley TD and Oberley LW (1996) An immunohistochemical analysis of antioxidant and glutathione S-transferase enzyme levels in normal and neoplastic human lung. Histol Histopathol 11: 851–860
Demjek A and Hjerpe A (1994) Carcinoembryonic antigen-like reactivity in malignant mesothelioma. Cancer 73: 464–469
Gaffey MJ, Mills SE, Swanson PE, Zarbo RJ, Shah AR and Wick MR (1992) Immunoreactivity for BER-EP4 in adenocarcinomas, adenomatoid tumours and malignant mesotheliomas. Am J Surg Pathol 16: 593–599
Hammar SP (1994) Pleural diseases. In: Pulmonary Pathology, Dail DA and Hammar SP (eds), pp. 1463–1579. Springer-Verlag: New York
Janssen AML, Bosman CB, Sier CFM, Griffioen G, Kubben FJGM, Lamers CBHW, van Krieken JHJM, van de Velde CJH and Verspaget HW (1998) Superoxide dismutases in relation to the overall survival of colorectal cancer patients. Br J Cancer 78: 1051–1057
Janssen YMW, Marsh JP, Driscoll KE, Borm PJA, Odersdörster G and Mossman BT (1994) Increased expression of manganese-containing superoxide dismutase in rat lungs after inhalation of inflammatory and fibrogenic minerals. Free Rad Biol Med 16: 315–322
Kahlos K, Anttila S, Asikainen T, Kinnula K, Raivio KO, Mattson K, Linnainmaa K and Kinnula VL (1998) Manganese superoxide dismutase in healthy pleural mesothelium and in malignant pleural mesothelioma. Am J Respir Cell Mol Biol 18: 570–580
Ke Y, Reddel RR, Gerwin BI, Reddel HK, Somers ANA, McMenamin MG, LaVeck MA, Stahel RA, Lechner JF and Harris CC (1989) Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma. Am J Pathol 134: 979–991
Kinnula VL, Chang L-Y, Everitt JI and Crapo JD (1992) Oxidants and antioxidants in alveolar epithelial type II cells: in situ, freshly isolated, and cultured cells. Am J Physiol 262: L69–L77
Kinnula VL, Yankaskas JR, Chang LY, Virtanen I, Linnala A, Kang BH and Crapo JD (1994) Primary and immortalized (BEAS2B) human bronchial epithelial cells have significant antioxidative capacity in vitro. Am J Respir Cell Mol Biol 11: 568–576
Kinnula VL, Crapo JD and Raivio KO (1995) Generation and disposal of reactive oxygen metabolites in the lung. Lab Invest 73: 3–19
Kinnula VL, Pietarinen-Runtti P, Kahlos K, Pelin K, Mattson K and Linnainmaa K (1996) Manganese superoxide dismutase in human pleural mesothelioma cell lines. Free Rad Biol Med 21: 527–532
Laemmli VK (1970) Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature 227: 680–684
Lakari E, Pääkkö P and Kinnula VL (1998) Manganese superoxide dismutase, but not CuZn superoxide dismutase, is highly expressed in the granulomas of pulmonary sarcoidosis and extrinsic allergic alveolitis. Am J Respir Crit Care Med 158: 589–596
Landriscina M, Remiddi F, Ria F, Palazzotti B, de Leo ME, Iacoangeli M, Rosseli R, Scerrati M and Galeotti T (1996) The level of MnSOD is directly correlated with grade of brain tumours of neuroepithelial origin. Br J Cancer 74: 1877–1885
Leers MPG, Aarts MMJ and Theunissen PHMH (1998) E-cadherin and calretin: a useful combination of immunohistochemical markers for differentiation between mesothelioma and metastatic adenocarcinoma. Histopathology 32: 209–216
Mossman BT, Marsh JP and Shatos MA (1986) Alteration of superoxide dismutase activity in tracheal epithelial cells by asbestos and inhibition of cytotoxicity by antioxidants. Lab Invest 54: 204–212
Mossman BT, Kamp DW and Weitzman SA (1996) Mechanisms of carcinogenesis and clinical features of asbestos-associated cancers. Cancer Invest 14: 466–480
Nishida S, Akai F, Iwasaki H, Hosokawa K, Kusunoki T, Suzuki K, Taniguchi N, Hashimoto S and Tamura TT (1993) Manganese superoxide dismutase content and localization in human thyroid tumors. J Pathol 169: 341–345
Oberley LW and Buettner GR (1979) Role of superoxide dismutase in cancer: a review. Cancer Res 39: 1141–1149
Oberley LW and Oberley TD (1997) Role of antioxidant enzymes in the cancer phenotype. In: Lung Biology in Health and Disease, Clerch LB and Massaro DJ (eds) vol. 105, pp. 279–308. Marcel Dekker: New York
Pelin K, Hirvonen A and Linnainmaa K (1994) Expression of cell adhesion molecules and connexins in gap junctional intercellular communication competent primary mesothelial cells. Carcinogenesis 15: 2673–2675
Pelin-Enlund K, Husgafvel-Pursiainen K, Tammilehto L, Klockars M, Jantunen K, Gerwin BI, Harris CC, Tuomi T, Vanhala E, Mattson K and Linnainmaa K (1990) Asbestos-related malignant mesothelioma: growth, cytology, tumorigenicity, and consistent chromosome findings in cell lines from five patients. Carcinogenesis 11: 673–681
Pietarinen-Runtti P, Raivio KO, Linnainmaa K, Ekman A, Saksela M and Kinnula VL (1996) Differential effects of tumor necrosis factor and asbestos fibers on manganese superoxide dismutase induction and oxidant-induced cytotoxicity in human mesothelial cells. Cell Biol Toxicol 12: 167–175
Ruitenbeek T, Gouw ASH and Poppema S (1994) Immunocytology of body cavity fluids: MOC-31, a monoclonal antibody discriminating between mesothelial and epithelial cells. Arch Pathol Lab Med 118: 265–269
Tsan MF, White JE, Santana TA and Lee CY (1990) Tracheal insufflation of tumor necrosis factor protects rats against oxygen toxicity. J Appl Physiol 68: 1211–1219
Ungar S, van de Meeren A, Tammilehto L, Linnainmaa K, Mattson K and Gerwin BI (1994) High levels of MDM2 are not correlated with the presence of wild-type p53 in human malignant mesothelioma cell lines. Br J Cancer 74: 1534–1540
van der Kwast TH, Versnel MA, Delahaye M, de Jong A, Zondervan PE and Hoogsteden H (1988) Expression of epithelial membrane antigen on malignant mesothelioma cells. An immunocytochemical and immunoelectron microscopic study. Acta Cytol 32: 169–174
van Driel BEM, Lyon H, Hoogenraad DCJ, Anten S, Hansen U and van Noorden CJF (1997) Expression of CuZn- and Mn-superoxide dismutase in human colorectal neoplasms. Free Rad Biol Med 23: 435–444
Wispe JR, Warner BB, Clark JC, Dey CR, Neuman S, Glasser S, Crapo JD, Chang L-Y and Whitsett JA (1992) Human Mn-superoxide dismutase in pulmonary epithelial cells of transgenic mice confers protection from oxygen injury. J Biol Chem 267: 23937–23941
Wong GH and Goeddel DV (1988) Induction of manganese superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science 242: 941–944
WHO (1981) Histological Typing of Lung Tumours. International Classification of Tumours, 2nd edn. World Health Organization: Geneva
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Kahlos, K., Pääkkö, P., Kurttila, E. et al. Manganese superoxide dismutase as a diagnostic marker for malignant pleural mesothelioma. Br J Cancer 82, 1022–1029 (2000). https://doi.org/10.1054/bjoc.1999.1037
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.1037
Keywords
This article is cited by
-
Mechanisms of oxidative stress and alterations in gene expression by Libby six-mix in human mesothelial cells
Particle and Fibre Toxicology (2010)
-
Decreased expression of antioxidant enzymes is associated with aggressive features in ependymomas
Journal of Neuro-Oncology (2008)
-
Antioxidant enzymes in oligodendroglial brain tumors: association with proliferation, apoptotic activity and survival
Journal of Neuro-Oncology (2006)